biolitec AG
- ISIN AT0000A0VCT2
- Country Österreich
Company profile
biolitec AG develops, produces and distributes devices and methods for the treatment of diseases by using most recent laser technology and novel substances.
Photodynamic Therapy (PDT) provides treatment options in many areas through the use of light-activated substances and the corresponding lasers.
biolitec’s production sites are located in Europe, USA and South-East Asia. Research and development of photosensitizers is located in the Biotechnologie-Zentrum in Jena (Germany). Currently biolitec has 235 employees.
The competence and the complete range of photoactive substances (photosensitizers), minimally invasive laser technology and highly flexible probes (optical fibers) form the foundation for the market leadership biolitec aims to achieve as manufacturer of innovative treatment methods.
In the current fiscal year biolitec invested more than 14 per cent of its revenue into the development of photosensitizers, devices and treatment methods, which exceeds the industry average substantially.
Photodynamic Therapy (PDT) provides treatment options in many areas through the use of light-activated substances and the corresponding lasers.
biolitec’s production sites are located in Europe, USA and South-East Asia. Research and development of photosensitizers is located in the Biotechnologie-Zentrum in Jena (Germany). Currently biolitec has 235 employees.
The competence and the complete range of photoactive substances (photosensitizers), minimally invasive laser technology and highly flexible probes (optical fibers) form the foundation for the market leadership biolitec aims to achieve as manufacturer of innovative treatment methods.
In the current fiscal year biolitec invested more than 14 per cent of its revenue into the development of photosensitizers, devices and treatment methods, which exceeds the industry average substantially.